ALNY vs RPAY · P/E 76, rev $1.29B vs rev $181.5M
Alnylam Pharmaceuticals Inc (ALNY) versus Repay Holdings Corp (RPAY) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Repay Holdings Corp (RPAY) is a software - infrastructure company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported RPAY revenue for 2026-06-30 was $181.5M. Net income was -$20.9M. RPAY currently screens at market cap $292.4M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. RPAY currently screens at market cap $292.4M.
Not investment advice. Open the ALNY and RPAY stock pages for the full models.
Not investment advice.